Global Nasal Drug Delivery Technology Market Size To Worth USD 151.3 Billion by 2033 | CAGR of 7.29%
Category: HealthcareGlobal Nasal Drug Delivery Technology Market Size To Worth USD 151.3 Billion by 2033
According to a research report published by Spherical Insights & Consulting, the Global Nasal Drug Delivery Technology Market Size is to Grow from USD 74.89 Billion in 2023 to USD 151.3 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 7.29% during the projected period.
Get more details on this report -
Browse key industry insights spread across 190 pages with 110 Market data tables and figures & charts from the report on the "Global Nasal Drug Delivery Technology Market Size, Share, and COVID-19 Impact Analysis, By Dosage Form (Nasal Spray, Nasal Drop, Nasal Gel, Nasal Powder), By Container Type (Pressurized Containers, and Non-pressurized Containers), By Therapeutic Application (Nasal Congestion, Rhinitis, Asthma, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/nasal-drug-delivery-technology-market
Nasal drug delivery technology is a method of administering drugs through the nose that allows them to be quickly absorbed into the bloodstream. This method of administration avoids the digestive system and liver, where drugs can be degraded or metabolized. Because the nasal cavity has a rich blood supply and a large surface area, the rate of absorption for drugs from this route is extremely fast, resulting in faster action than oral delivery. Technology is most commonly used to administer decongestants and pain relievers, as well as to treat migraines and epilepsy. Nasal delivery holds promise for vaccines, hormone treatments, and pharmaceuticals used to treat chronic diseases like diabetes. Technological advancements are enabling the creation of novel nasal drug delivery systems with enhanced targeted delivery, controlled release, and bioavailability. These advancements are contributing to more effective and patient-centered treatment options. However, the complex structure of the nasal cavity, with narrow spaces and a limited absorption surface area, influences drug delivery and distribution.
The nasal spray segment dominates the market with the highest market share of the global nasal drug delivery technology market during the projected period.
Based on the dosage form, the global nasal drug delivery technology market is divided into nasal spray, nasal drop, nasal gel, and nasal powder. Among these, the nasal spray segment dominates the market with the highest market share of the nasal drug delivery technology market during the projected period. As infections and allergic rhinitis rates rise, so will the demand for generic nasal spray drugs. Rising demand for self-administration and improved patient compliance will also contribute to market growth. The nasal spray's long-term effect will be to reduce swelling and mucus in the nose.
The non-pressurized segment is anticipated to grow at the fastest pace during the projected timeframe.
Based on the container type, the global nasal drug delivery technology market is categorized into pressurized containers and non-pressurized containers. Among these, the non-pressurized containers segment is anticipated to grow at the fastest pace during the projected timeframe. Nasal drops, nasal powder, and nasal gels are primarily filled in non-pressurized containers, and a rise in demand for related products is expected to fuel segment growth over the forecast period. Additionally, according to an article by Intertek Group plc, nasal drug delivery technologies can deliver drugs systematically or topically.
The rhinitis segment is anticipated to grow at the fastest pace during the projected timeframe.
Based on the therapeutic application, the global nasal drug delivery technology market is categorized into nasal congestion, rhinitis, asthma, and others. Among these, the rhinitis segment is anticipated to grow at the fastest pace during the projected timeframe. The American Academy of Allergy, Asthma, and Immunology estimates that allergic rhinitis affects between 10% and 30% of the global population. Sinusitis affects approximately 13% of the general population over the age of 18. Antihistamines: Loratadine (Claritin), Cetirizine (Zyrtec), Fexofenadine (Allegra), Levocetirizine (Xyzal); decongestants: Afrin nasal spray, Phenylephrine nasal spray (Neo-Synephrine), and pseudoephedrine (Sudafed).
North America is expected to hold the largest share of the global nasal drug delivery technology market over the forecast period
Get more details on this report -
North America is expected to hold the largest share of the global nasal drug delivery technology market over the forecast period. Asthma and chronic obstructive pulmonary disease are becoming increasingly prevalent, and early treatment methods are widely used. Chronic obstructive pulmonary disease is the third leading internal cause of death in the United States. Because of the increased incidence of COPD, more people will use nasal drug delivery devices.
Asia Pacific is predicted to grow at the fastest pace in the global nasal drug delivery technology market during the projected period. As investments in R&D activities increase, so does the prevalence of chronic diseases and public awareness. This factor, when combined with large pools of patients and critical health professionals in China and India's rapidly developing economies, presents opportunities for growth. Government funding increases healthcare expenditure in the region.
Major vendors in the global nasal drug delivery technology market are Aptar Pharma, Merck & Co., Inc., Vectura Group, Johnson & Johnson Services, Inc., AstraZeneca PLC, Pfizer, Inc., OptiNose, Inc., Becton, Dickinson and Company, Promius Pharma, LLC, Cadila Pharmaceuticals Ltd., B.F. Ascher & Company, Inc., PendoPharm, Inc., Douglas Pharmaceuticals Ltd., ENT Technologies Pty. Ltd., NAVEH Pharma Ltd., and Others.
Recent Developments
- In March 2021, Aptar Pharma and its subsidiary, Noble, formed a partnership with Dne Pharma, a leader in addiction medicine in Northern Europe. The companies provide nasal drug delivery expertise and training solutions for Dne Pharma's Ventizolve nasal naloxone to treat opioid overdoses.
Key Target Audience
- MarketPlayers
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global nasal drug delivery technology market based on the below-mentioned segments:
Global Nasal Drug Delivery Technology Market, By Dosage Form
- Nasal Spray
- Nasal Drop
- Nasal Gel
- Nasal Powder
Global Nasal Drug Delivery Technology Market, By Container Type
- Pressurized Containers
- Non-pressurized Containers
Global Nasal Drug Delivery Technology Market, By Therapeutic Application
- Nasal Congestion
- Rhinitis
- Asthma
- Others
Global Nasal Drug Delivery Technology Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?